In the past, oncologists had to test different chemotherapy drugs on patients based on medical guidelines until finding an effective one. This trial-and-error approach often caused severe side effects, weakened the immune system, and in some cases led to patient death.
Today, with global scientific advances and genetic profiling, chemotherapy drugs can be tailored to each individual’s biology, eliminating unnecessary trials. It is also possible to identify drugs currently under FDA approval, which can be prescribed if the physician accepts the associated risks.
Medic Metaverse will soon launch its “Chemotherapy Drug Selection Package.” By uploading genetic information, patients will receive a personalized list of drugs most effective against their specific cancer.
